Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.515 USD | +2.39% | +1.52% | -4.42% |
Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.42% | 104M | |
-1.94% | 103B | |
+0.47% | 95.71B | |
+1.69% | 22.02B | |
-17.39% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.03% | 15.52B | |
+3.46% | 13.86B | |
+35.16% | 12.04B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics : Wells Fargo Adjusts Price Target on Sangamo Therapeutics to $29 From $36, Maintains Overweight Rating